Breaking News Instant updates and real-time market news.

BKI

Black Knight

$58.09

1.4 (2.47%)

, AMCX

AMC Networks

$54.13

1.36 (2.58%)

10:05
06/03/19
06/03
10:05
06/03/19
10:05

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Black Knight (BKI) upgraded to Buy from Neutral at Goldman Sachs with analyst James Schneider saying the company's "strong" pipeline of new bank client wins in both mortgage servicing and origination software should drive accelerating revenue growth over 2019 and into 2020 relative to recent quarters. 2. AMC Networks (AMCX) upgraded to In-Line from Underperform at Imperial Capital with analyst David Miller citing valuation. 3. BT Group (BT) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Sidney saying he has a "much increased" level of confidence in the company's ability to return to sustainable EBITDA growth in fiscal 2021. 4. Brinker (EAT) upgraded to Neutral from Sell at UBS with analyst Dennis Geiger saying that with the stock falling below that level, valuation now appears to reflect the challenges of his April initiation. 5. Teva (TEVA) upgraded to Outperform from Perform at Oppenheimer with analyst Esther Rajavelu saying the shares, trading at its 19-year low, offer a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

BKI

Black Knight

$58.09

1.4 (2.47%)

AMCX

AMC Networks

$54.13

1.36 (2.58%)

BT

BT Group

$12.41

0.01 (0.08%)

EAT

Brinker

$38.15

0.59 (1.57%)

TEVA

Teva

$9.14

0.5 (5.79%)

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 12

    Jun

  • 12

    Jun

  • 18

    Jun

  • 26

    Jun

  • 13

    Nov

BKI Black Knight
$58.09

1.4 (2.47%)

04/15/19
PIPR
04/15/19
NO CHANGE
PIPR
Piper says FinTech secular drives 'remain strong' into Q1 results
While absolute and relative valuations in FinTech are back near the all-time highs, the Federal Reserve "has moved from a headwind last Fall to a Neutral factor for economic growth and equity valuations," Piper Jaffray analyst Jason Deleeuw tells investors in a research note. Also, the ongoing secular drivers for FinTech "remain strong" as global payments and business ecosystems digitize, says the analyst. He remains constructive on FinTech names heading into Q1 earnings and also tells investors to look at some mortgage/real estate services stocks. Deleeuw's top ideas are Black Knight (BKI), Redfin (RDFN), Euronet (EEFT) and Cannae Holdings (CNNE). He also boosted his price target for Overweight-rated Euronet to $171 from $159, for Overweight-rated Global Payments (GPN) to $163 from $152, for Overweight-rated MasterCard (MA) to $272 from $262, for Neutral-rated PayPal (PYPL) to $104 from $97, for Overweight-rated Visa (V) to $191 from $178 and for Neutral-rated Worldpay (WP) to $115 from $101.
06/03/19
GSCO
06/03/19
UPGRADE
Target $68
GSCO
Buy
Black Knight upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst James Schneider upgraded Black Knight to Buy from Neutral and raised his price target for the shares to $68 from $58. The company's "strong" pipeline of new bank client wins in both mortgage servicing and origination software should drive accelerating revenue growth over 2019 and into 2020 relative to recent quarters, Schneider tells investors in a research note. He expects this new revenue to come in at incremental margins of over 70%, translating to mid-teens earnings growth. Further, there are "key counter-cyclical elements" to Black Knight's model which will limit downside risk in a recession, says Schneider.
05/02/19
LEHM
05/02/19
NO CHANGE
Target $66
LEHM
Overweight
Black Knight price target raised to $66 from $56 at Barclays
Barclays analyst Mark DeVries raised his price target for Black Knight to $66 from $56 saying the company's growth is on track following its Q1 results. The analyst believes Black Knight is well positioned to benefit from a potential flow through in the Exchange business. He says the company remains one of the more defensive names in his sector and reiterates an Overweight rating on the shares.
11/30/18
BTIG
11/30/18
INITIATION
BTIG
Neutral
Ocwen initiated with a Neutral at BTIG
As reported earlier, BTIG analyst Giuliano Bologna initiated Ocwen with a Neutral rating as part of his broader research note into Mortgage Servicers. The analyst notes that in spite of the rising interest rate tail risk, the stock does not represent an "attractive opportunity currently due to the wide range of potential outcomes during the company's turnaround". Bologna adds that the range of outcomes should narrow and his investment thesis will become clearer as Ocwen progresses toward its goals of "cutting costs, integrating the PHH Corp (PHH) acquisition and boarding current loans onto the Black Knight (BKI) LoanSphere.
AMCX AMC Networks
$54.13

1.36 (2.58%)

06/03/19
IMPC
06/03/19
UPGRADE
Target $53
IMPC
In-Line
AMC Networks upgraded to In-Line from Underperform at Imperial Capital
Imperial Capital analyst David Miller upgraded AMC Networks to In-Line from Underperform with an unchanged price target of $53. The analyst, despite lowering his 2019 earnings estimate due to higher production costs, cites valuation for the upgrade with the shares down 15% since January 31. He believes AMC's lack of 2019 growth is now priced into the shares.
01/31/19
01/31/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMC Networks (AMCX) downgraded to Underperform from In-Line at Imperial Capital with analyst David Miller saying he reduced his fiscal 2019 estimates for the company to reflect his expectation of lower scatter effects for The Walking Dead, as well as higher overall production costs. 2. General Dynamics (GD) downgraded to Hold from Buy at Argus with analyst John Eade saying the company's latest results topped consensus, but the growth outlook for 2019 in low single digits was disappointing. 3. Allergan (AGN) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan citing "underwhelming" 2019 guidance and given additional questions he has on the strength of its business. 4. Steven Madden (SHOO) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Dana Telsey saying while Steven Madden has a lot to like, external factors, such as tariffs and a wholesale channel that has a "more muted tone" entering 2019 as compared to 2018, may weigh on the stock price. 5. PayPal (PYPL) downgraded to Hold from Buy at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/31/19
IMPC
01/31/19
DOWNGRADE
Target $56
IMPC
Underperform
AMC Networks downgraded to Underperform from In-Line at Imperial Capital
Imperial Capital analyst David Miller downgraded AMC Networks to Underperform and lowered his price target for the shares to $56 from $64. The analyst reduced his fiscal 2019 estimates for the company to reflect his expectation of lower scatter effects for The Walking Dead, as well as higher overall production costs. Miller believes now is the time to trim positions in AMC in favor of "other, higher-quality SMID names" in Media/Entertainment. AMC is now the only vertically integrated networks entity within that refuses to embrace a branded direct-to-consumer strategy, Miller tells investors in a research note. He points out that subscriber growth is already beginning to slow within the skinny bundle universe.
12/07/18
WOLF
12/07/18
INITIATION
Target $66
WOLF
Underperform
AMC Networks initiated with an Underperform at Wolfe Research
Wolfe Research initiated AMC Networks with an Underperform rating and $66 price target.
BT BT Group
$12.41

0.01 (0.08%)

12/17/18
NWST
12/17/18
UPGRADE
NWST
Buy
BT Group upgraded to Buy from Neutral at New Street
02/26/19
BREN
02/26/19
DOWNGRADE
BREN
Hold
BT Group downgraded to Hold from Buy at Berenberg
06/03/19
FBCO
06/03/19
UPGRADE
FBCO
Outperform
BT Group upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Paul Sidney upgraded BT Group to Outperform from Neutral and raised his price target for the shares to 2.80 pounds from 2.70 pounds. The analyst has a "much increased" level of confidence in the company's ability to return to sustainable EBITDA growth in fiscal 2021.
01/31/19
BOFA
01/31/19
DOWNGRADE
BOFA
Neutral
BT Group downgraded to Neutral from Buy at BofA/Merrill
EAT Brinker
$38.15

0.59 (1.57%)

06/03/19
06/03/19
UPGRADE
Target $39

Neutral
Brinker upgraded to Neutral from Sell at UBS
As previously reported, UBS analyst Dennis Geiger upgraded Brinker to Neutral with an unchanged price target of $39, saying that with the stock falling below that level, valuation now appears to reflect the challenges of his April initiation. The analyst notes that the company's sales are still expected to decelerate over the next few quarters, while cost headwinds should continue to weigh on earnings and margins in FY20.
06/03/19
UBSW
06/03/19
UPGRADE
UBSW
Neutral
Brinker upgraded to Neutral from Sell at UBS
05/24/19
STFL
05/24/19
NO CHANGE
Target $57
STFL
Buy
Brinker selloff yesterday a good buying opportunity, says Stifel
Stifel analyst Chris O'Cull attributes the 6% selloff yesterday in shares of Brinker International to concerns about the potential for rising protein prices related to the African Swine Fever breakout in Asia. The analyst, while acknowledging protein prices are likely to rise for the restaurant industry, believes the recent pullback in Brinker reflects an overly cautious view of the African Swine Fever's impact on margins. The company's commodity hedges limit exposure for several quarters, says O'Cull, who keeps a Buy rating on the shares with a $57 price target.
04/26/19
UBSW
04/26/19
INITIATION
Target $39
UBSW
Sell
Brinker initiated with a Sell at UBS
UBS analyst Dennis Geiger initiated Brinker with a Sell rating and a price target of $39, citing his concerns over the "sustainability of improved deal-driven traffic and sales trends" at Chili's and their headwinds on margins pressuring earnings. The analyst warns about risk to the recent comps strength and believes that after a strong Q3 result, comps will "decelerate over time" on tougher compares and lapped promotional initiatives. Geiger expects Brinker to generate low-single-digit revenue and low-to-mid- single digit earnings growth over the next 3 years.
TEVA Teva
$9.14

0.5 (5.79%)

06/03/19
OPCO
06/03/19
UPGRADE
Target $12
OPCO
Outperform
Oppenheimer upgrades Teva, despite legal uncertainty, with stock at 19-year low
Oppenheimer analyst Esther Rajavelu upgraded Teva Pharmaceutical to Outperform from Perform while lowering her price target for the shares to $12 from $17. The stock closed Friday down 19c to $8.65. The shares, trading at its 19-year low, offer a buying opportunity, Rajavelu tells investors in a research note. The analyst believes Teva's business fundamentals continue to improve and that management's execution on the operational front is generally in line with expectations. She acknowledges, however, that legal uncertainties could remain an overhang the stock. Rajavelu estimates the company's opioid liability exposure at $500M-$700M and believes its price-fixing exposure could be "substantially higher." Teva's balance sheet, assuming the refinancing of certain debt tranches, could sustain $400M in average annual penalties over time, says the analyst.
06/03/19
OPCO
06/03/19
UPGRADE
Target $12
OPCO
Outperform
Teva upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Esther Rajavelu upgraded Teva Pharmaceutical to Outperform from Perform with a $12 price target.
05/30/19
05/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying with the valuation back in-line with historical levels and more difficult comps ahead, Verizon's risk/reward is more balanced at current share levels. 2. Canada Goose (GOOS) downgraded to Neutral from Buy at BofA/Merrill with analyst Robert Ohmes saying the Direct-to-Consumer, or DTC, slowdown indicates saturation risk and warrants a lower multiple. 3. ViaSat (VSAT) downgraded to Market Perform from Outperform at Raymond James with analyst Rick Prentiss saying shares are up 55% year-to-date, reflecting good news, and expects an increase in R&D and capex from VS-3 satellite builds and deployments, expanding LatAm operations, and acquiring STCs. 4. Teva (TEVA) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Gerberry saying Teva's financial downside to ongoing opioid litigation is difficult to gauge and the highly fragmented nature of the lawsuits makes a global settlement unlikely. 5. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Raymond James with analyst Buck Horne saying he is "concerned" that shares will be range-bound near-term due to reduced estimates, a lack of upcoming catalysts, and lingering West Coast issues. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/30/19
WELS
05/30/19
NO CHANGE
WELS
U.S. generic data continues to show challenging environment, says Wells Fargo
Wells Fargo analyst David Maris says that according to April IQVIA data, Teva (TEVA) U.S. generic sales were down 19% in April year over year, while brands sales were down 15%. Additionally, according to IQVIA data, Teva recently ceded its second place U.S. prescription market share place to competitor Eli Lilly (LLY) for its migraine drug, Ajovy, he points out. For Mylan (MYL), Maris says the monthly trends also paint a negative picture, with IQVIA U.S. generic sales in April down 36%. Nonetheless, the analyst believes Teva and Mylan shares seem to be reflecting an "aggressively negative outlook" given the current earnings multiples, and setting aside the worst-case outcomes in the opioid and price fixing cases, these may be at or nearing attractive valuations. However, for now, he remains on the sidelines, and within generics, continues to recommend Outperform-rated Amphastar (AMPH).

TODAY'S FREE FLY STORIES

SENS

Senseonics

$0.83

-0.021 (-2.46%)

16:09
10/14/19
10/14
16:09
10/14/19
16:09
Hot Stocks
Senseonics announces HCSC now provides coverage for Eversense CGM System »

Senseonics announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$100.74

4.94 (5.16%)

16:07
10/14/19
10/14
16:07
10/14/19
16:07
Hot Stocks
Reata Pharmaceuticals Part 2 MOXIe trial of omaveloxolone meets primary endpoint »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$30.31

-0.11 (-0.36%)

16:07
10/14/19
10/14
16:07
10/14/19
16:07
Hot Stocks
Sanmina names Kurt Adzema as CFO, succeeding David Anderson »

Sanmina (SANM) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QGEN

Qiagen

$27.29

0.21 (0.78%)

16:07
10/14/19
10/14
16:07
10/14/19
16:07
Hot Stocks
Qiagen launches new QIAseq FastSelect Solutions »

QIAGEN announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPAY

Repay Holdings

$13.18

-0.1 (-0.75%)

16:06
10/14/19
10/14
16:06
10/14/19
16:06
Hot Stocks
Repay Holdings to acquire APS Payments for $60M »

Repay Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

AKS

AK Steel

$2.44

-0.07 (-2.79%)

, MT

ArcelorMittal

$14.34

-0.415 (-2.81%)

16:01
10/14/19
10/14
16:01
10/14/19
16:01
General news
Trump says steel tariffs on Turkey to be raised back up to 50% »

President Trump announced…

AKS

AK Steel

$2.44

-0.07 (-2.79%)

MT

ArcelorMittal

$14.34

-0.415 (-2.81%)

NUE

Nucor

$51.61

-1.08 (-2.05%)

STLD

Steel Dynamics

$29.55

-0.82 (-2.70%)

X

U.S. Steel

$11.14

-0.2 (-1.76%)

TMST

TimkenSteel

$5.71

-0.115 (-1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 31

    Oct

RETA

Reata Pharmaceuticals

$101.70

5.9 (6.16%)

16:00
10/14/19
10/14
16:00
10/14/19
16:00
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPAY

Repay Holdings

$13.18

-0.1 (-0.75%)

16:00
10/14/19
10/14
16:00
10/14/19
16:00
Hot Stocks
Breaking Hot Stocks news story on Repay Holdings »

Repay Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

AEMD

Aethlon Medical

$0.26

0.0016 (0.63%)

15:56
10/14/19
10/14
15:56
10/14/19
15:56
Hot Stocks
Aethlon Medical announces 1-for-15 reverse stock split »

Aethlon Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

AYTU

Aytu BioScience

$1.22

0.01 (0.83%)

15:55
10/14/19
10/14
15:55
10/14/19
15:55
Conference/Events
Aytu BioScience to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

JNJ

Johnson & Johnson

$130.78

-0.57 (-0.43%)

15:53
10/14/19
10/14
15:53
10/14/19
15:53
Earnings
Fly Intel: What to watch in Johnson & Johnson earnings report »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

RGSE

RGS Energy

$0.00

(0.00%)

15:50
10/14/19
10/14
15:50
10/14/19
15:50
Conference/Events
RGS Energy to host business news update conference call »

Business Update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGNA

Tegna

$15.21

0.05 (0.33%)

15:50
10/14/19
10/14
15:50
10/14/19
15:50
Periodicals
Tegna investor Standard General considering proxy fight, Bloomberg says »

Standard General is said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

15:33
10/14/19
10/14
15:33
10/14/19
15:33
Conference/Events
Wolfe Research utilities analyst to hold a group luncheon »

Utilities Analysts…

RCUS

Arcus Biosciences

$8.12

-0.075 (-0.92%)

15:26
10/14/19
10/14
15:26
10/14/19
15:26
Conference/Events
Arcus Biosciences management to meet with SVB Leerink »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

MLND

Millendo Therapeutics

$7.09

-0.15 (-2.07%)

15:24
10/14/19
10/14
15:24
10/14/19
15:24
Conference/Events
Millendo Therapeutics management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

MREO

Mereo BioPharma

$3.40

-0.15 (-4.23%)

15:22
10/14/19
10/14
15:22
10/14/19
15:22
Conference/Events
Mereo BioPharma management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/14/19
10/14
15:17
10/14/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/14/19
10/14
15:16
10/14/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$35.48

-0.885 (-2.43%)

15:11
10/14/19
10/14
15:11
10/14/19
15:11
Downgrade
Fastenal rating change  »

Fastenal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PE

Parsley Energy

$15.27

-1.71 (-10.07%)

, JAG

Jagged Peak Energy

$6.76

-0.055 (-0.81%)

15:00
10/14/19
10/14
15:00
10/14/19
15:00
Recommendations
Parsley Energy, Jagged Peak Energy analyst commentary  »

Parsley Energy deal to…

PE

Parsley Energy

$15.27

-1.71 (-10.07%)

JAG

Jagged Peak Energy

$6.76

-0.055 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 06

    Nov

CURO

Curo Group

$12.76

-0.1 (-0.78%)

, GOOG

Alphabet

$1,220.44

6.58 (0.54%)

15:00
10/14/19
10/14
15:00
10/14/19
15:00
Recommendations
Curo Group, Alphabet, Alphabet Class A, Elevate Credit, Enova International, Apple analyst commentary  »

Google App Store ban…

CURO

Curo Group

$12.76

-0.1 (-0.78%)

GOOG

Alphabet

$1,220.44

6.58 (0.54%)

GOOGL

Alphabet Class A

$1,220.24

5.62 (0.46%)

ELVT

Elevate Credit

$4.42

-0.03 (-0.67%)

ENVA

Enova International

$19.99

0.03 (0.15%)

AAPL

Apple

$236.16

-0.05 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 13

    Nov

ZUO

Zuora

$14.37

-0.29 (-1.98%)

14:55
10/14/19
10/14
14:55
10/14/19
14:55
Options
Zuora put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.06

0.155 (0.54%)

, GS

Goldman Sachs

$205.68

0.98 (0.48%)

14:54
10/14/19
10/14
14:54
10/14/19
14:54
Earnings
Fly Intel: What to watch in next round of big banks' earnings reports »

Goldman Sachs (GS), Bank…

BAC

Bank of America

$29.06

0.155 (0.54%)

GS

Goldman Sachs

$205.68

0.98 (0.48%)

MS

Morgan Stanley

$42.19

0.25 (0.60%)

BABA

Alibaba

$171.95

-1.015 (-0.59%)

FDC

First Data

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 17

    Oct

  • 27

    Oct

  • 10

    Nov

  • 12

    Nov

  • 19

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/14/19
10/14
14:17
10/14/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.